IFRX ▼ -8.8% - InflaRx N.V.
$IFRX - InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan
06-NOV-2026 07:30 AM ET
Share this post
More filings for $IFRX
IFRX ▼ -1.7% - InflaRx N.V.Nov 3, 2026IFRX ▲ +1.9% - InflaRx N.V.Oct 27, 2026IFRX ▲ +0.6% - InflaRx N.V.Oct 22, 2026IFRX ▲ +2.3% - InflaRx N.V.Oct 2, 2026IFRX ▼ -2.4% - InflaRx N.V.Sep 21, 2026IFRX - InflaRx N.V. - SEC Filing Update (17-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 17, 2026
View full $IFRX filing history →💬 Comments
Loading comments…
Leave a comment